Technical Analysis for STRO - Sutro Biopharma, Inc.

Grade Last Price % Change Price Change
D 19.3 -3.98% -0.80
STRO closed down 3.98 percent on Monday, April 12, 2021, on 88 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical STRO trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness -3.98%
Multiple of Ten Bullish Other -3.98%
Older End-of-Day Signals for STRO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 11 hours ago
Down 3% about 12 hours ago
Down 2 % about 12 hours ago
Down 1% about 12 hours ago
Fell Below Previous Day's Low about 12 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Sutro Biopharma, Inc. Description

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers. It has collaboration and license agreement with Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Biology Immunology Antibodies Drug Discovery Lymphoma Cancer Treatments Antineoplastic Drugs Multiple Myeloma Immune Disorders Sutro Biopharma Autoimmune Disorders Endometrial Cancer Hodgkin Lymphoma Immunogen Non Hodgkin Lymphoma Therapeutics For Cancer Ovarian And Endometrial Cancers

Is STRO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 28.3
52 Week Low 7.06
Average Volume 509,758
200-Day Moving Average 16.48
50-Day Moving Average 23.05
20-Day Moving Average 22.69
10-Day Moving Average 21.72
Average True Range 1.65
ADX 12.6
+DI 15.74
-DI 30.71
Chandelier Exit (Long, 3 ATRs ) 20.91
Chandelier Exit (Short, 3 ATRs ) 23.74
Upper Bollinger Band 25.66
Lower Bollinger Band 19.71
Percent B (%b) -0.07
BandWidth 26.23
MACD Line -0.63
MACD Signal Line -0.29
MACD Histogram -0.3486
Fundamentals Value
Market Cap 745.06 Million
Num Shares 38.6 Million
EPS 0.44
Price-to-Earnings (P/E) Ratio 43.76
Price-to-Sales 10.67
Price-to-Book 2.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.85
Resistance 3 (R3) 20.84 20.33 20.59
Resistance 2 (R2) 20.33 19.93 20.33 20.50
Resistance 1 (R1) 19.81 19.69 19.56 19.82 20.42
Pivot Point 19.30 19.30 19.17 19.30 19.30
Support 1 (S1) 18.78 18.90 18.53 18.79 18.18
Support 2 (S2) 18.27 18.66 18.27 18.10
Support 3 (S3) 17.75 18.27 18.01
Support 4 (S4) 17.76